Compounds > mesulergine
Page last updated: 2024-08-25

mesulergine and Interstitial Cell Tumor

mesulergine has been researched along with Interstitial Cell Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooke, BA; Dirami, G; Teerds, KJ1
Donatsch, P; Ettlin, RA; Prentice, DE; Qureshi, S; Siegel, RA1

Other Studies

2 other study(ies) available for mesulergine and Interstitial Cell Tumor

ArticleYear
Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats.
    Toxicology and applied pharmacology, 1996, Volume: 141, Issue:1

    Topics: Adenoma; Animals; Antiparkinson Agents; Body Weight; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Extracellular Space; Hyperplasia; Leydig Cell Tumor; Leydig Cells; Male; Organ Size; Rats; Rats, Sprague-Dawley; Testicular Neoplasms

1996
Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1992, Volume: 15

    Topics: Animals; Dihydropyridines; Ergolines; Isradipine; Leydig Cell Tumor; Male; Pituitary Hormones; Rats; Rats, Inbred Strains; Syndrome; Testicular Hormones; Time Factors

1992